EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections

Christian Janke iD, Raquel Rubio-Acero, Maximilian Weigert, Christina Reinkemeyer iD, Yeganeh Khazaei, Lisa Kleinlein, Ronan Le Gleut iD, Katja Radon, Marlene Hannes, Francesco Picasso, Anne Elisabeth Lucke, Michael Plank und 10 weitere

Viruses · 2024

DOI: 10.3390/v16101556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Christian Janke und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Health Personnel, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, European Union’s Horizon 2020 research and innovation program, German Federal Ministry of Education and Research (BMBF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study analyzes immune responses to SARS-CoV-2 vaccination and infection, including asymptomatic cases, focusing on infection risks during the Omicron wave, particularly among high-risk healthcare workers. In the KoCo-Impf study, we monitored 6088 vaccinated participants in Munich aged 18 and above. From 13 May to 31 July 2022, 2351 participants were follow-uped. Logistic regression models evaluated primary, secondary, and breakthrough infections (BTIs). Roche Elecsys® Anti-SARS-CoV-2 assays detected prior infections (via anti-Nucleocapsid antibodies) and assessed vaccination/infection impact (via anti-Spike antibodies) using dried blood spots. Our findings revealed an anti-Nucleocapsid seroprevalence of 44.1%. BTIs occurred in 38.8% of participants, with reinfections in 48.0%. Follow-up participation was inversely associated with current smoking and non-vaccination, while significantly increasing with age and receipt of three vaccine doses. Larger household sizes and younger age increased infection risks, whereas multiple vaccinations and older age reduced them. Household size and specific institutional subgroups were risk factors for BTIs. The anti-Nucleocapsid value prior to the second infection was significantly associated with reinfection risk. Institutional subgroups influenced all models, underscoring the importance of tailored outbreak responses. The KoCo-Impf study underscores the importance of vaccination, demographic factors, and institutional settings in understanding SARS-CoV-2 infection risks during the Omicron wave.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Health PersonnelAntibodies, ViralCOVID-19 VaccinesReinfectionVaccinationHumansAdultMaleFemaleMiddle AgedRisk FactorsGermanyProspective StudiesSeroepidemiologic StudiesYoung AdultAgedAdolescentBreakthrough Infections

Stichwörter der Autor:innen

COVID-19ORCHESTRASARS-CoV-2antibodiesbreakthrough infectionshealth care workersimmunologic responsereinfectionsseroprevalencevaccination

Substanzen

Antibodies, ViralCOVID-19 Vaccines

Autor:innen und Institutionen

  • Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, 80802 Munich, Germany.
  • Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, 80539 Munich, Germany.
  • Munich Center for Machine Learning (MCML), 80539 Munich, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology, Infection and Pandemic Research, 80799 Munich, Germany.
  • Institute of Computational Biology, Helmholtz Munich, 85764 Neuherberg, Germany.
  • Core Facility Statistical Consulting, Helmholtz Munich, 85764 Neuherberg, Germany.

ORCID-Profile: Christian Janke, Christina Reinkemeyer, Ronan Le Gleut, Ana Zhelyazkova, Michael Hoelscher

Förderung

  • European Union
  • European Union’s Horizon 2020 research and innovation program
  • German Federal Ministry of Education and Research (BMBF)

Zitieren

APA

Janke, C., Rubio-Acero, R., Weigert, M., Reinkemeyer, C., Khazaei, Y., Kleinlein, L., Le Gleut, R., Radon, K., Hannes, M., Picasso, F., Lucke, A. E., Plank, M., Kotta, I. C., Paunovic, I., Zhelyazkova, A., Noreña, I., Winter, S., Hoelscher, M., Wieser, A., …, & On Behalf Of The Orchestra Working Group (2024). Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections. Viruses. https://doi.org/10.3390/v16101556

Vancouver

Janke C, Rubio-Acero R, Weigert M, Reinkemeyer C, Khazaei Y, Kleinlein L, et al. Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections. Viruses. 2024. doi:10.3390/v16101556

BibTeX
@article{Janke2024,
  author = {Janke, Christian and Rubio-Acero, Raquel and Weigert, Maximilian and Reinkemeyer, Christina and Khazaei, Yeganeh and Kleinlein, Lisa and Le Gleut, Ronan and Radon, Katja and Hannes, Marlene and Picasso, Francesco and Lucke, Anne Elisabeth and Plank, Michael and Kotta, Irene Charlotte and Paunovic, Ivana and Zhelyazkova, Ana and Noreña, Ivan and Winter, Simon and Hoelscher, Michael and Wieser, Andreas and Küchenhoff, Helmut and Castelletti, Noemi and On Behalf Of The Orchestra Working Group},
  title = {Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101556}
}
Kostenlos starten →